How Investors Are Reacting To Tempus AI (TEM) Earnings Surge and New Lymphoma Research Partnership
Tempus AI recently reported third quarter 2025 earnings, highlighted by revenue of US$334.21 million, up from US$180.93 million a year...
Lymphoma
Tempus AI recently reported third quarter 2025 earnings, highlighted by revenue of US$334.21 million, up from US$180.93 million a year...
